HF 402

as introduced - 90th Legislature (2017 - 2018) Posted on 01/23/2017 01:39pm

A bill for an act
relating to health; establishing a pilot project for genetic marker testing.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

Section 1. new text begin GENETIC MARKER TESTING PILOT PROGRAM.
new text end

new text begin Subdivision 1. new text end

new text begin Establishment. new text end

new text begin The commissioner of management and budget in
collaboration with the commissioner of health shall establish a genetic marker testing pilot
program. The commissioner of management and budget shall enlist volunteers from the
state employees group insurance plan (SEGIP) to participate in the program. Minnesota
Management and Budget shall oversee the administrative aspects of the program. The
program is intended to refine the understanding of disease onset and progression, treatment
response, and health outcomes through more precise measurement of genetic factors that
contribute to health and disease.
new text end

new text begin Subd. 2. new text end

new text begin Program design. new text end

new text begin (a) Between 2,500 and 5,000 participants shall be selected
from enrollees in the Blue Cross Blue Shield Advantage plan pool under SEGIP. One-third
of the participants shall be randomly selected. The program shall be conducted over a
four-year period. All participation in the program is voluntary.
new text end

new text begin (b) The commissioner of management and budget shall partner with Mayo Clinic Biobank
to collect and store biospecimens from all program participants. Mayo Clinic Biobank shall
utilize its established privacy, security, and systems protocols and protections for this pilot
program. Mayo Clinic shall partner with the University of Minnesota to develop and oversee
the scientific study details, testing components, and selection of participants. Mayo Clinic
and the University of Minnesota shall form an oversight committee to design the volunteer
agreement participants must sign in order to join the pilot program.
new text end

new text begin (c) Mayo Clinic Biobank shall release the results of testing to the participant's primary
care provider upon request of the participant and with the participant's signed release of
information authorization.
new text end

new text begin (d) The commissioner of management and budget shall obtain information from
participants' primary care providers after obtaining a signed release of information from
each participant. This information will be used to determine savings in health outcomes and
health care costs.
new text end

new text begin Subd. 3. new text end

new text begin Report. new text end

new text begin The commissioner of management and budget shall issue an annual
report to the legislative committees with jurisdiction over health care. The report must
specify the status of the program including any significant savings in health outcomes and
lives saved and detail health care costs avoided.
new text end